Halozyme Therapeutics Inc (NASDAQ:HALO)

19.16
Delayed Data
As of Apr 19
 -0.41 / -2.10%
Today’s Change
11.41
Today|||52-Week Range
21.48
-5.43%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close19.57
Today’s open19.55
Day’s range19.05 - 19.76
Volume648,744
Average volume (3 months)1,106,292
Market cap$2.9B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-284.74%
Earnings growth (next 5 years)+22.89%
Revenue growth (last year)+115.84%
P/E ratio42.6
Price/Sales8.90
Price/Book14.13

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.37-3.90%
BPMCBlueprint Medicines ...-3.52-4.06%
XLRNAcceleron Pharma Inc-1.35-3.62%
XONIntrexon Corp-0.79-4.19%
Data as of 4:02pm ET, 04/19/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$316.6M
Annual profit (last year)$63.0M
Net profit margin19.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts